125 related articles for article (PubMed ID: 27352182)
1. The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer.
Yang XW; Gao F; Chen YJ; Teng FM
Cell Biochem Biophys; 2015 Jul; 72(3):649-52. PubMed ID: 27352182
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T; Konno H; Baba M; Tanaka T; Nakamura S
Cancer Sci; 2003 Jan; 94(1):43-9. PubMed ID: 12708473
[TBL] [Abstract][Full Text] [Related]
3. Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
Zhang L; Zhao ZS; Ru GQ; Ma J
World J Gastroenterol; 2006 Jul; 12(25):3970-6. PubMed ID: 16810742
[TBL] [Abstract][Full Text] [Related]
4. Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients.
Konukoglu D; Turhan MS; Celik V; Turna H
Indian J Med Res; 2007 Jun; 125(6):747-51. PubMed ID: 17704550
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of hemostatic molecular markers expression in patients with cancer].
Wu F; Qu B; Wang XF; Yang CM; Wang HL
Zhonghua Nei Ke Za Zhi; 2004 Nov; 43(11):837-40. PubMed ID: 15634544
[TBL] [Abstract][Full Text] [Related]
6. Involvement of vascular endothelial growth factor and urokinase-type plasminogen activator receptor in microvessel invasion in human colorectal cancers.
Nakata S; Ito K; Fujimori M; Shingu K; Kajikawa S; Adachi W; Matsuyama I; Tsuchiya S; Kuwano M; Amano J
Int J Cancer; 1998 Apr; 79(2):179-86. PubMed ID: 9583734
[TBL] [Abstract][Full Text] [Related]
7. Urokinase system expression in gastric carcinoma: prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens.
Beyer BC; Heiss MM; Simon EH; Gruetzner KU; Babic R; Jauch KW; Schildberg FW; Allgayer H
Cancer; 2006 Mar; 106(5):1026-35. PubMed ID: 16435385
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator.
Berney CR; Yang JL; Fisher RJ; Russell PJ; Crowe PJ
Anticancer Res; 1998; 18(2A):973-7. PubMed ID: 9615749
[TBL] [Abstract][Full Text] [Related]
10. [Expression of vascular endothelial growth factor C and survivin in gastric carcinoma and their clinical implications].
Sun YS; Ye ZY; Zhao ZS; Shi D; Zou SC
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):264-7. PubMed ID: 16721694
[TBL] [Abstract][Full Text] [Related]
11. [Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof].
Zhang FH; Zhou YN; Li GZ; Li Q; Lu B; Zhang ZY; Wu ZQ; Fan P; Hao TJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3279-82. PubMed ID: 19159555
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo.
Weiss TW; Simak R; Kaun C; Rega G; Pflüger H; Maurer G; Huber K; Wojta J
Anticancer Res; 2011 Oct; 31(10):3273-8. PubMed ID: 21965736
[TBL] [Abstract][Full Text] [Related]
14. Significance of vascular endothelial growth factor expression and its correlation with inducible nitric oxide synthase in gastric cancer.
Song ZY; Wen SQ; Peng JP; Huang X; Qian KD
World J Gastroenterol; 2004 May; 10(9):1250-5. PubMed ID: 15112337
[TBL] [Abstract][Full Text] [Related]
15. [The expression of nicotinamide phosphoribosyl transferase and vascular endothelial growth factor-A in gastric carcinoma and their clinical significance].
Long HL; Che XM; Bi TQ; Li HJ; Liu JS; Li DW
Zhonghua Wai Ke Za Zhi; 2012 Sep; 50(9):839-42. PubMed ID: 23157963
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis.
Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S
Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968
[TBL] [Abstract][Full Text] [Related]
17. Differential biological significance of tissue-type and urokinase-type plasminogen activator in human breast cancer.
Yamashita J; Ogawa M; Yamashita S; Nakashima Y; Saishoji T; Nomura K; Inada K; Kawano I
Br J Cancer; 1993 Sep; 68(3):524-9. PubMed ID: 8394731
[TBL] [Abstract][Full Text] [Related]
18. Correlation of integrin beta3 mRNA and vascular endothelial growth factor protein expression profiles with the clinicopathological features and prognosis of gastric carcinoma.
Li SG; Ye ZY; Zhao ZS; Tao HQ; Wang YY; Niu CY
World J Gastroenterol; 2008 Jan; 14(3):421-7. PubMed ID: 18200665
[TBL] [Abstract][Full Text] [Related]
19. Correlations between Her2 oncoprotein, VEGF expression, MVD and clinicopathological parameters in gastric cancer.
Bădescu A; Georgescu CV; Vere CC; Crăiţoiu S; Grigore D
Rom J Morphol Embryol; 2012; 53(4):997-1005. PubMed ID: 23303024
[TBL] [Abstract][Full Text] [Related]
20. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
